Skip to content

Clinical trials

Phase 2 Waldenstrom Macroglobulinemia trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Waldenstrom Macroglobulinemia Phase: Phase 2 Country / region: France Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20082
20111
20141
20172
20211
20221
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Active, not recruiting3
Not yet recruiting1
Recruiting1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
French Innovative Leukemia Organisation2
Acerta Pharma BV1
Assistance Publique - Hôpitaux de Paris1
BeOne Medicines1
Cellectar Biosciences, Inc.1
Eli Lilly and Company1
European Organisation for Research and Treatment of Cancer - EORTC1
Gilead Sciences1
Jonsson Comprehensive Cancer Center1
Kite, A Gilead Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Waldenstrom Macroglobulinemia12
Lymphoma, Non-Hodgkin4
Leukemia, Lymphocytic, Chronic, B-Cell3
Lymphoma3
Lymphoma, B-Cell, Marginal Zone3
Multiple Myeloma3
Burkitt Lymphoma2
Leukemia, Hairy Cell2
Lymphoma, Follicular2
Lymphoma, Large B-Cell, Diffuse2

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.